Rottendorf is totally owned and controlled by the Rottendorf Foundation.
Main purpose of the Rottendorf Foundation is to promote scientific work in the field of pharmaceutical research as well as charitable projects.
Strongly defined foundation bylaws ensure that the company can not be sold, can act economically totally independent and can focus on sustainable and outstanding corporate social responsibility.
All these aspects in combination create significant advantages for our customers and therefore lead to a competitive advantage for our global positioned technology company.
The foundation background enables our employees to focus solely on the needs of our customers and their products.
Targets and deadlines regarding the proportion of women
The target proportion of women on the Supervisory Board of Rottendorf GmbH is to be at least 33% (2 persons) in accordance with § 52 (2) GmbHG. The target of at least 33 % was achieved in July 2023 with a proportion of 50 % (3 persons). The target proportion of women on the management board is also to be at least 33% (1 person). The target figure of at least 33% was achieved in July 2023 with a proportion of 50% (1 person). All targets are to be achieved by December 31, 2026.
